Jim Simons Singular Genomics Systems, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Singular Genomics Systems, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 111,200 shares of OMIC stock, worth $32,247. This represents 0.0% of its overall portfolio holdings.
Number of Shares
111,200
Previous 151,450
26.58%
Holding current value
$32,247
Previous $70,000
18.57%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding OMIC
# of Institutions
45Shares Held
24.7MCall Options Held
13.2KPut Options Held
0-
Deerfield Management Company, L.P. (Series C) New York, NY4.98MShares$1.45 Million0.05% of portfolio
-
Arch Venture Management, LLC Chicago, IL3.8MShares$1.1 Million2.82% of portfolio
-
Qvidtvm Management LLC New York, NY2.51MShares$726,9411.08% of portfolio
-
Ubs Group Ag2.21MShares$640,7210.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.13MShares$616,7980.02% of portfolio
About Singular Genomics Systems, Inc.
- Ticker OMIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 71,193,296
- Market Cap $20.6M
- Description
- Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...